John C. Aplin, Director at ENDOCYTE INC (ECYT), bought 20,000 shares at $3.27 ($65K) on 2011-12-16, disclosed to the SEC on 2011-12-16.
Open-market purchase of $65k ECYT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.